Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
125.80
+1.96 (1.58%)
At close: Nov 4, 2025, 4:00 PM EST
125.59
-0.21 (-0.17%)
After-hours: Nov 4, 2025, 7:59 PM EST
Period EndingSep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Medical Devices
20.76B20.06B19.43B18.99B18.38B17.88B17.44B16.89B
Medical Devices Growth
12.99%12.22%11.40%12.43%13.48%14.90%16.10%14.98%
Diagnostics
9.00B9.16B9.18B9.34B9.36B9.39B9.51B9.99B
Diagnostics Growth
-3.79%-2.48%-3.50%-6.48%-13.05%-21.61%-31.97%-39.77%
Nutrition
8.64B8.55B8.49B8.41B8.32B8.33B8.26B8.15B
Nutrition Growth
3.82%2.69%2.86%3.18%4.90%8.80%9.60%9.32%
Established Pharmaceuticals
5.42B5.32B5.23B5.19B5.15B5.11B5.10B5.07B
Established Pharmaceuticals Growth
5.32%4.05%2.45%2.53%1.74%1.83%3.01%3.14%
Other
17.00M17.00M16.00M16.00M15.00M15.00M14.00M14.00M
Other Growth
13.33%13.33%14.29%14.29%15.38%25.00%27.27%27.27%
Period EndingSep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
International
26.76B26.12B25.70B25.63B25.29B25.18B24.96B24.66B
International Growth
5.83%3.75%2.98%3.93%4.33%3.93%2.40%-3.35%
United States
17.08B16.99B16.65B16.32B15.93B15.55B15.37B15.45B
United States Growth
7.24%9.27%8.30%5.64%1.33%-2.83%-10.29%-14.83%
Period EndingSep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Selling, General, and Administrative
12.11B11.95B11.80B11.70B11.51B11.34B11.15B10.95B
Selling, General, and Administrative Growth
5.18%5.40%5.86%6.83%2.82%1.21%-0.69%-2.66%
Research and Development
2.96B2.90B2.88B2.84B2.80B2.75B2.77B2.74B
Research and Development Growth
5.76%5.41%3.79%3.76%1.05%-4.24%-2.60%-5.09%
Amortization
1.73B1.78B1.83B1.88B1.89B1.92B1.95B1.97B
Amortization Growth
-8.92%-7.55%-6.21%-4.48%-4.39%-3.18%-2.26%-2.33%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.